4 false false false false false false false false false true false false false false false false No description of principal activity 2022-12-01 Sage Accounts Production Advanced 2021 - FRS102_2021 xbrli:pure xbrli:shares iso4217:GBP 10495543 2022-12-01 2023-11-30 10495543 2023-11-30 10495543 2021-12-01 2022-11-30 10495543 2022-11-30 10495543 bus:RegisteredOffice 2022-12-01 2023-11-30 10495543 bus:LeadAgentIfApplicable 2022-12-01 2023-11-30 10495543 bus:Director1 2022-12-01 2023-11-30 10495543 bus:Director2 2022-12-01 2023-11-30 10495543 core:WithinOneYear 2023-11-30 10495543 core:WithinOneYear 2022-11-30 10495543 core:AfterOneYear 2023-11-30 10495543 core:AfterOneYear 2022-11-30 10495543 core:RestatedAmount 2022-11-30 10495543 bus:Micro-entities 2022-12-01 2023-11-30 10495543 bus:AuditExemptWithAccountantsReport 2022-12-01 2023-11-30 10495543 bus:FullAccounts 2022-12-01 2023-11-30 10495543 bus:SmallCompaniesRegimeForAccounts 2022-12-01 2023-11-30 10495543 bus:PrivateLimitedCompanyLtd 2022-12-01 2023-11-30
COMPANY REGISTRATION NUMBER: 10495543
Lester Oncology Limited
Filleted Unaudited Financial Statements
30 November 2023
Lester Oncology Limited
Financial Statements
Year ended 30 November 2023
CONTENTS
PAGE
Officers and professional advisers
1
Statement of financial position and the notes to the financial statements
2
Lester Oncology Limited
Officers and Professional Advisers
The board of directors
Dr J Lester
Dr R S Lester
Registered office
2nd Floor Rear Office
7a Nevill Street
Abergavenny
Wales
NP7 5AA
Accountants
James & Uzzell Ltd
Chartered Certified Accountants
Axis 15, Axis Court
Mallard Way
Riverside Business Park
Swansea
SA7 0AJ
Lester Oncology Limited
Statement of Financial Position
30 November 2023
2023
2022
£
£
Fixed assets
74,118
14,662
--------
--------
Current assets
681,238
829,468
Creditors: amounts falling due within one year
253,393
263,371
---------
---------
NET CURRENT ASSETS
427,845
566,097
---------
---------
TOTAL ASSETS LESS CURRENT LIABILITIES
501,963
580,759
Creditors: amounts falling due after more than one year
50,936
75,612
---------
---------
451,027
505,147
---------
---------
Capital and reserves
451,027
505,147
---------
---------
NOTES TO THE FINANCIAL STATEMENTS
1. EMPLOYEE NUMBERS
The average number of persons employed by the company during the year amounted to 4 (2022: 3 ).
2. DIRECTORS' ADVANCES, CREDITS AND GUARANTEES
The total owed from the directors to the company at the year end was £4,097 (2022, £8,393cr) No interest has been charged in relation to this balance
3. OTHER FINANCIAL COMMITMENTS
Total financial commitments, guarantees and contingencies which are not included in the balance sheet amount to £13,125 (2022: £15,993).
For the year ending 30 November 2023 the company was entitled to exemption from audit under section 477 of the Companies Act 2006 relating to small companies.
Directors' responsibilities:
- The members have not required the company to obtain an audit of its financial statements for the year in question in accordance with section 476 ;
- The directors acknowledge their responsibilities for complying with the requirements of the Act with respect to accounting records and the preparation of financial statements .
These financial statements have been prepared in accordance with the micro-entity provisions and have been delivered in accordance with the provisions applicable to companies subject to the small companies regime.
These financial statements were approved by the board of directors and authorised for issue on 29 August 2024 , and are signed on behalf of the board by:
Rhian Sian Lester
Dr R S Lester
Director
Company registration number: 10495543
Lester Oncology Limited is a private company limited by shares incorporated in England & Wales, United Kingdom. The address of the registered office is given in the company information on page 1 of these financial statements.